Cyclipostins, a method for their production and the use of the same

Details for Australian Patent Application No. 2001262229 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Kurz, Michael; Vertesy, Laszlo; Ehrlich, Klaus; Wink, Joachim

Agent Watermark

Pub. Number AU-B-2001262229

PCT Pub. Number WO01/83497

Priority 10021731 04.05.00 DE

Filing date 25 April 2001

Wipo publication date 12 November 2001

Acceptance publication date 25 January 2007

International Classifications

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

A61K 31/665 (2006.01) - having oxygen as a ring hetero atom, e.g. fosfomycin

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07F 9/6574 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12P 9/00 (2006.01) Preparation of organic compounds containing a metal or atom other than H, N, C, O, S, or halogen

C12R 1/465 (2006.01)

Event Publications

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

25 January 2007 Application Accepted

  Published as AU-B-2001262229

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001262230

2001262228